Testing effectiveness (Phase 2)Ended earlyNCT00527982
What this trial is testing
Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer
Who this might be right for
Head and Neck CancerLung Cancer
M.D. Anderson Cancer Center 1